B&L appoints senior vice president for R&D

Bausch & Lomb names Praveen Tyle, PhD, its senior vice president of research and development (R&D) and chief scientific officer.

Dr. Tyle joins Bausch & Lomb from Biovail Corp., where he served since 2003 as group vice president of pharmaceutical sciences and manufacturing. He also spent 4 years at Pharmacia Corp., where he was most recently vice president and global head of pharmaceutical sciences.

"Dr. Tyle brings to Bausch & Lomb a record of success in moving products from the laboratory to the market," said Ronald L. Zarrella, Bausch & Lomb chairman and chief executive officer, in a company statement. "Perhaps equally important is his extensive experience in drug development, an area of key strategic for our company. We're confident he'll provide strong scientific leadership as the company significantly increases its commitment to R&D."